title: The Case ∣ Metabolic alkalosis in a patient with cystic fibrosis.
authors.affiliation: Columbia University Medical Center, Division of Nephrology, New York, New York 10032, USA. ag3094@columbia.edu
authors.forename: Abdallah S
authors.initials: AS
authors.lastname: Geara
authors.forename: Amay
authors.initials: A
authors.lastname: Parikh
authors.forename: Yelena
authors.initials: Y
authors.lastname: Rekhtman
authors.forename: Maya K
authors.initials: MK
authors.lastname: Rao
mesh_terms: D000328:Adult; D000471:Alkalosis / Q000209:etiology*; D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001477:Bartter Syndrome / Q000139:chemically induced* / Q000150:complications; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D014031:Tobramycin / Q000009:adverse effects* / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D014031:Tobramycin